In vitro trypanocidal activities of a novel series of N,N-dimethyl-2-propen-1-amine derivative

Microbios

Volumn 85, Issue 343, 1996, Pages 83-87

  De Conti, R ^a   Santa Rita, R M ^b   De Souza, E M ^b   Melo, P S ^a   Haun, M ^a   De Castro, S L ^b   Duran N ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chagas's disease; Synthetic drugs; Trypanosoma cruzi

Indexed keywords

ANTITRYPANOSOMAL AGENT; PROPYLAMINE;

ANIMAL; ARTICLE; CELL DIVISION; CELL LINE; CRICETULUS; DRUG EFFECT; DRUG SCREENING; HAMSTER; TRYPANOSOMA CRUZI;

ANIMALS; CELL DIVISION; CELL LINE; CRICETINAE; CRICETULUS; DRUG EVALUATION, PRECLINICAL; PROPYLAMINES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0029687581     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BRENER Z. 1979. Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere. Pharmacol. Therap. 7 71-90.
2. DE CASTRO S. L. 1993. The challenge of Chagas's disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop. 64 368-75.
3. DE CASTRO S. L., Meirelles M. N. L. and Oliveira M. M. 1987. Trypanosoma cruzi: adrenergic modulation of cAMP role in proliferation and differentiation in vitro. Expl Parasitol. 64 368-75.
4. DE CASTRO S. L., Soeiro M. N. C., Higashi K. O. and Meirelles M. N. L 1993. Differential effect of amphotericin B on the three evolutionary stages of Trypanosoma cruzi and on the host cell-parasite interaction. Brazil. J. Med. Biol. Res. 26 1219-29
5. DE CASTRO S. L., Pinto M. C. F. R. and Pinto A. V. 1994. Screening of natural and synthetic drugs against Trypanosoma cruzi. 1. Establishing a structure/activity relationship. Microbios 78 83-90.
6. DE CONTI R., Gimenez S. M. N., Haun M., Pilli R. A., De Castro S. L and Durán N. 1995. Synthesis and biological activities of N,N-dimethyl-2-propen-1-amine derivatives. Bioorg. Med. Chem. Letters (Submitted for publication).
7. DURÁN N. and Haun M. 1991. Trypanocides: state of art. Mem. Inst. Oswaldo Cruz (RJ) (Suppl I) 86 29-30.
8. 2H-indol-2-one derivatives. Biol. Res. 25 21-5.
9. PINTO-DIAS J. C. 1992. Epidemiology of Chagas's disease. In Chagas's disease (American trypanosomiasis): Its Impact on Transfusion and Clinical Medicine, pp 49-80. Edited by S. Wendel, Z. Brener, M. E. Camargo and A. Rassi. ISBT Sāo Paulo, Brazil.
10. SCHLEMPER B. R., Chiari E. and Brener Z. 1977. Growth inhibition drug test with Trypanosoma cruzi culture forms. J. Protozool. 24 544-7.
11. SILVA L. H. P. and Nussenszweig V. 1953. Sobre uma cepa de Trypanosoma cruzi virulenta para o camundongo branco. Folia Clin. Biol. 32 191-207.
12. WORLD Health Organization (WHO). 1984. Meeting on the development of trypanocidal compounds for sterilization of blood. UNDP/WB/TDR, Geneva, Switzerland.